DJIA38904.04 307.06
S&P 5005204.34 57.13
NASDAQ16248.52 199.44
Russell 20002060.10 8.70
German DAX18163.94 -238.49
FTSE 1007911.16 -64.73
CAC 408061.31 -90.24
EuroStoxx 505013.35 -57.20
Nikkei 22538992.08 -781.06
Hang Seng16723.92 -1.18
Shanghai Comp3069.30 -5.66
KOSPI2714.21 -27.79
Bloomberg Comm IDX102.90 0.64
WTI Crude-fut91.17 0.01
Brent Crude-fut86.57 1.15
Natural Gas1.79 0.00
Gasoline-fut2.79 -0.01
Gold-fut2345.40 33.50
Silver-fut27.50 0.46
Platinum-fut940.60 -5.50
Palladium-fut1007.40 -23.60
Copper-fut423.60 1.85
Aluminum-spot1815.00 0.00
Coffee-fut212.50 5.75
Soybeans-fut1185.00 5.00
Wheat-fut567.25 11.00
Bitcoin67976.00 304.00
Ethereum USD3328.10 56.27
Litecoin98.71 0.69
Dogecoin0.18 0.00
EUR/USD1.0862 0.0007
USD/JPY151.72 -0.02
GBP/USD1.2678 0.0016
USD/CHF0.9044 -0.0014
USD IDX104.28 0.08
US 10-Yr TR4.4 0.091
GER 10-Yr TR2.406 0.007
UK 10-Yr TR4.064 -0.005
JAP 10-Yr TR0.771 -0.004
Fed Funds5.5 0
SOFR5.32 0
High-rise commercial buildings

Sub Markets

Topics

Direct Investment  + M&As  | 
Thoma Bravo, MDP Complete $1.4B Sale of Syntellis to Roper Technologies

Thoma Bravo, MDP Complete $1.4B Sale of Syntellis to Roper Technologies

Private equity firms Madison Dearborn Partners and Thoma Bravo have completed the sale of Syntellis Performance Solutions to Roper Technologies, Inc. in an all-cash transaction valued at $1.4 billion, including a $135 million tax benefit resulting from the transaction.

Syntellis is a provider of cloud-based performance management and data services for healthcare, financial institutions, and higher education. The company will be combined with Roper’s Strata Decision Technology business, which offers healthcare financial planning, decision support and performance management services.

The combined entity will operate under the Strata brand and led by Strata CEO John Martino.

Syntellis became an independent company with the investment support of Thoma Bravo and MDP when it was separated from Kaufman Hall in August 2020. Since then, the company has made product and platform investments, including to its Axiom365 SaaS offering, and enhanced its planning and performance product offering by acquiring Stratasan, a specialist in healthcare market intelligence and data analytics.

With planned cost efficiencies, Syntellis is anticipated to generate $185 million in sales and $85 million in EBITDA in 2024.

Roper used its cash on hand and revolving credit facility to finance the acquisition, which closed earlier this week.

Connect

Inside The Story

Syntellis Performance SolutionsMadison Dearborn PartnersThoma Bravo

About Joe Palmisano

Joe Palmisano is Editorial Director for Connect Money, where he brings nearly three decades experience of market insights as a financial journalist, analyst and senior portfolio manager for leading financial publications, advisory firms, and hedge funds. In his role as Editorial Director, Joe is responsible for the selection of content and creation of daily business news covering the financial markets, including Alternative Assets, Direct Investment and Financial Advisory services. Before joining Connect Money, Joe was a financial journalist for the Wall Street Journal, regularly publishing feature stories and trend pieces on the foreign exchange, global fixed income and equity markets. Joe parlayed his experience as a financial journalist into roles as a Senior Research Analyst and Portfolio Manager, writing daily and weekly market analysis and managing a FX and US equity portfolio. Joe was also a contributing writer for industry magazines and publications, including SFO Magazine and the CMT Association. Joe earned a B.S.B.A. in Finance from The American University. He holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.